These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 23899697)

  • 1. Genetic strain modification of a live rabies virus vaccine widely used in Europe for wildlife oral vaccination.
    Cliquet F; Robardet E; Picard Meyer E
    Antiviral Res; 2013 Oct; 100(1):84-9. PubMed ID: 23899697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic characterisation of attenuated SAD rabies virus strains used for oral vaccination of wildlife.
    Geue L; Schares S; Schnick C; Kliemt J; Beckert A; Freuling C; Conraths FJ; Hoffmann B; Zanoni R; Marston D; McElhinney L; Johnson N; Fooks AR; Tordo N; Müller T
    Vaccine; 2008 Jun; 26(26):3227-35. PubMed ID: 18485548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic characterisation of the rabies virus vaccine strains used for oral immunization of foxes in Poland to estimate the effectiveness of vaccination.
    Orłowska A; Żmudziński JF
    Arch Virol; 2015 Feb; 160(2):509-15. PubMed ID: 25408374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elimination of terrestrial rabies in Western European countries.
    Cliquet F; Aubert M
    Dev Biol (Basel); 2004; 119():185-204. PubMed ID: 15747421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic stability (in vivo) of the attenuated oral rabies virus vaccine SAD B19.
    Beckert A; Geue L; Vos A; Neubert A; Freuling C; Müller T
    Microbiol Immunol; 2009 Jan; 53(1):16-21. PubMed ID: 19161553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral vaccination of raccoons (Procyon lotor) with an attenuated (SAD-B19) rabies virus vaccine.
    Rupprecht CE; Dietzschold B; Cox JH; Schneider LG
    J Wildl Dis; 1989 Oct; 25(4):548-54. PubMed ID: 2810555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetically modified rabies virus ERA strain is safe and induces long-lasting protective immune response in dogs after oral vaccination.
    Shuai L; Feng N; Wang X; Ge J; Wen Z; Chen W; Qin L; Xia X; Bu Z
    Antiviral Res; 2015 Sep; 121():9-15. PubMed ID: 26093157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine-induced rabies in a red fox (Vulpes vulpes): isolation of vaccine virus in brain tissue and salivary glands.
    Hostnik P; Picard-Meyer E; Rihtarič D; Toplak I; Cliquet F
    J Wildl Dis; 2014 Apr; 50(2):397-401. PubMed ID: 24484500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experience with antirabies vaccination of foxes using the oral route coordinated among several European countries and perspectives on the use of recombinant vaccinia-rabies virus].
    Pastoret PP; Blancou J; Brochier B; Thomas I; Paquot A; Debruyn J; Costy F; Wolff F; Kieny MP; Languet B
    Parassitologia; 1988; 30(1):149-54. PubMed ID: 3268767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-Depth Characterization of Live Vaccines Used in Europe for Oral Rabies Vaccination of Wildlife.
    Cliquet F; Picard-Meyer E; Mojzis M; Dirbakova Z; Muizniece Z; Jaceviciene I; Mutinelli F; Matulova M; Frolichova J; Rychlik I; Celer V
    PLoS One; 2015; 10(10):e0141537. PubMed ID: 26509266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Safety and efficacy of an antirabies vaccine consisting of recombinant vaccinia-rabies virus administered orally to the fox, dog and cat].
    Blancou J; Artois M; Brochier B; Thomas I; Pastoret PP; Desmettre P; Languet B; Kiény MP
    Ann Rech Vet; 1989; 20(2):195-204. PubMed ID: 2751231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Successful Elimination of Sylvatic Rabies Using Oral Vaccination of Foxes in Slovenia.
    Černe D; Hostnik P; Toplak I
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33806582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of vaccine-virus-associated rabies cases in red foxes (Vulpes vulpes) after oral rabies vaccination campaigns in Germany and Austria.
    Müller T; Bätza HJ; Beckert A; Bunzenthal C; Cox JH; Freuling CM; Fooks AR; Frost J; Geue L; Hoeflechner A; Marston D; Neubert A; Neubert L; Revilla-Fernández S; Vanek E; Vos A; Wodak E; Zimmer K; Mettenleiter TC
    Arch Virol; 2009; 154(7):1081-91. PubMed ID: 19521660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deliberate release of a recombinant vaccinia-rabies virus for vaccination of wild animals against rabies.
    Pastoret PP; Brochier B; Coppens P
    Microb Releases; 1993 Mar; 1(4):191-5. PubMed ID: 8281357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twenty year experience of the oral rabies vaccine SAG2 in wildlife: a global review.
    Mähl P; Cliquet F; Guiot AL; Niin E; Fournials E; Saint-Jean N; Aubert M; Rupprecht CE; Gueguen S
    Vet Res; 2014 Aug; 45(1):77. PubMed ID: 25106552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large-scale eradication of rabies using recombinant vaccinia-rabies vaccine.
    Brochier B; Kieny MP; Costy F; Coppens P; Bauduin B; Lecocq JP; Languet B; Chappuis G; Desmettre P; Afiademanyo K
    Nature; 1991 Dec 19-26; 354(6354):520-2. PubMed ID: 1758494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral and cell-mediated immune responses of foxes (Vulpes vulpes) after experimental primary and secondary oral vaccination using SAG2 and V-RG vaccines.
    Lambot M; Blasco E; Barrat J; Cliquet F; Brochier B; Renders C; Krafft N; Bailly J; Munier M; Aubert MF; Pastoret PP
    Vaccine; 2001 Feb; 19(13-14):1827-35. PubMed ID: 11166908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of three oral rabies vaccine-baits in the red fox: a comparison.
    Artois M; Masson E; Barrat J; Aubert MF
    Vet Microbiol; 1993 Dec; 38(1-2):167-72. PubMed ID: 8128598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and safety of recombinant rabies viruses used for oral vaccination of stray dogs and wildlife.
    Faber M; Dietzschold B; Li J
    Zoonoses Public Health; 2009 Aug; 56(6-7):262-9. PubMed ID: 19486317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Environmental distribution of certain modified live-virus vaccines with a high safety profile presents a low-risk, high-reward to control zoonotic diseases.
    Head JR; Vos A; Blanton J; Müller T; Chipman R; Pieracci EG; Cleaton J; Wallace R
    Sci Rep; 2019 May; 9(1):6783. PubMed ID: 31043646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.